Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 17 matching records.
17 results — page 1 of 1
- Level DAnimal StudyEurope PMC
Efficacy of mesenchymal stem cell therapy for treating deep corneal ulcers and corneal perforation in cats: a retrospective study
Animal Study, published in J Feline Med Surg (2026) — summary generated from the PubMed abstract.
- 2026
J Feline Med Surg - Level DNarrative ReviewEurope PMC
Hydrogels loaded with different substances for treating heart failure: a promising therapy
Narrative Review on Cardiovascular Disease, published in Front Cardiovasc Med (2026) — summary generated from the PubMed abstract.
- 2026
Front Cardiovasc Med - Level DNarrative ReviewEurope PMC
Stem cell-derived exosome delivery systems for treating atherosclerosis: The new frontier of stem cell therapy
Narrative Review on Cardiovascular Disease, published in Mater Today Bio (2025) — summary generated from the PubMed abstract.
- 2025
Mater Today Bio11 citations - Level DAnimal StudyEurope PMC
MSC-exosomes pretreated by Danshensu extracts pretreating to target the hsa-miR-27a-5p and STAT3-SHANK2 to enhanced antifibrotic therapy
Animal Study on Hip, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther10 citations - Level DNarrative ReviewEurope PMC
Translational Challenges in Drug Therapy and Delivery Systems for Treating Chronic Lower Extremity Wounds
Narrative Review on Diabetic Foot, Chronic Wound, Burns, published in Pharmaceutics (2024) — summary generated from the PubMed abstract.
- 2024
Pharmaceutics9 citations - Level AMeta-analysisPubMed
20 years of treating ischemic cardiomyopathy with mesenchymal stromal cells: a meta-analysis and systematic review.
Meta-analysis with a reported sample of 33 on Cardiovascular Disease, published in Cytotherapy (2024) — summary generated from the PubMed abstract.
- 2024
- n = 33
Cytotherapy - Level BClinical TrialEurope PMC
A comprehensive evaluation of dermal fibroblast therapy in clinical trials for treating skin disorders and cosmetic applications: a scoping review
Clinical Trial on Diabetic Foot, Chronic Wound, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther7 citations - Level ASystematic ReviewPubMed
The Application of Mesenchymal Stem Cell Therapy in Treating Pulmonary Fibrosis: A Scoping Review.
Systematic Review on Scar, published in Cureus (2024) — summary generated from the PubMed abstract.
- 2024
Cureus1 citations - Level DNarrative ReviewEurope PMC
Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes
Narrative Review on Type 1 Diabetes, published in Cell Stem Cell (2023) — summary generated from the PubMed abstract.
- 2023
Cell Stem Cell154 citations - Level BClinical TrialPubMed
Stem Cell Therapy in Treating Epilepsy.
Clinical Trial, published in Front Neurosci (2022) — summary generated from the PubMed abstract.
- 2022
Front Neurosci13 citations - Level ASystematic ReviewPubMed
Cell therapy efficacy and safety in treating tendon disorders: a systemic review of clinical studies.
Systematic Review with a reported sample of 658 on Tendon Injury, Rotator Cuff, published in J Exp Orthop (2022) — summary generated from the PubMed abstract.
- 2022
- n = 658
J Exp Orthop16 citations - Level DNarrative ReviewEurope PMC
Multipronged Attack of Stem Cell Therapy in Treating the Neurological and Neuropsychiatric Symptoms of Epilepsy
Narrative Review on Neuroinflammation, published in Front Pharmacol (2021) — summary generated from the PubMed abstract.
- 2021
Front Pharmacol8 citations - Level DNarrative ReviewEurope PMC
Targeting Programmed Cell Death to Improve Stem Cell Therapy: Implications for Treating Diabetes and Diabetes-Related Diseases
Narrative Review on Systemic / IV, published in Front Cell Dev Biol (2021) — summary generated from the PubMed abstract.
- 2021
Front Cell Dev Biol24 citations - Level DLaboratory StudyPubMed
Stem Cell Transplantation Therapy: A Potential Method for Treating Cytokine Storm Syndromes Induced by COVID-19.
Laboratory Study, published in Cell Transplant (2020) — summary generated from the PubMed abstract.
- 2020
Cell Transplant - Level AMeta-analysisEurope PMC
Clinical Efficacy and Safety of Stem Cell-Based Therapy in Treating Asherman Syndrome: A System Review and Meta-Analysis
Meta-analysis with a reported sample of 3, published in Stem Cells Int (2020) — summary generated from the PubMed abstract.
- 2020
- n = 3
Stem Cells Int19 citations - Level DNarrative ReviewEurope PMC
Stem cell therapy for treating osteonecrosis of the femoral head: From clinical applications to related basic research
Narrative Review on Hip, published in Stem Cell Res Ther (2018) — summary generated from the PubMed abstract.
- 2018
Stem Cell Res Ther52 citations - Level DLaboratory StudyPubMed
Adipose Derived Regenerative Cell Therapy for Treating a Diabetic Wound: A Case Report.
Laboratory Study on Diabetic Foot, Chronic Wound, published in Wounds (2012) — summary generated from the PubMed abstract.
- 2012
Wounds6 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406